Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Reckitt is indeed after Merck's consumer unit, and it's ready for a close race
Fierce Pharma
Tuesday, April 29, 2014 - 3:15pm
tags:
Reckitt Benckiser, Merck, consumer health, M&A, Bayer
Could This Be the Next Health Care Acquisition Target?
Motley Fool
Tuesday, April 29, 2014 - 3:11pm
tags:
M&A, GSK, Theravance, Anoro Ellipta
Bristol-Myers racing to the FDA with immunotherapy star nivolumab
Fierce Biotech
Tuesday, April 29, 2014 - 10:05am
tags:
FDA, immunotherapy, nivolumab, Bristol-Myers Squibb
Shire Gains on Report Allergan Is Preparing Takeover Bid
Bloomberg
Tuesday, April 29, 2014 - 9:57am
tags:
Shire, Allergan, M&A, Valeant Pharmaceuticals
Dendreon: How About Some Good News For Once?
Seeking Alpha
Tuesday, April 29, 2014 - 9:48am
tags:
Dendreon, earnings
Allergan Said to Explore Sale to Sanofi, J&J
Bloomberg
Tuesday, April 29, 2014 - 9:44am
tags:
Allergan, Sanofi, JNJ, M&A, Valeant Pharmaceuticals
Celgene anemias treatment granted FDA orphan designation
Yahoo/Fly on the Wall
Tuesday, April 29, 2014 - 9:43am
tags:
FDA, Celgene, anemia, sotatercept
[video]Why Did Forest Laboratories Buy Furiex Pharmaceuticals?
Motley Fool
Tuesday, April 29, 2014 - 9:37am
tags:
M&A, Forest Labs, Furiex Pharmaceuticals
Pfizer’s Bid May Have Been Invited by U.K.’s Tax Policy
Bloomberg
Tuesday, April 29, 2014 - 8:27am
tags:
Pfizer, M&A, UK, taxes, AstraZeneca
Actavis sues U.S. drug regulator over generic Celebrex
Yahoo/Reuters
Tuesday, April 29, 2014 - 8:27am
tags:
Actavis, generics, Pfizer, Celebrex, patents, FDA, Teva Pharmaceuticals, Mylan
Sanofi CEO says focusing on smaller, 'bolt-on' deals, WSJ reports
Yahoo/Fly on the Wall
Tuesday, April 29, 2014 - 8:25am
tags:
Sanofi, Pharma CEOs, M&A, Chris Viehbacher
Wockhardt in Talks to Sell India Drugs Business, ET Now Reports
Bloomberg
Tuesday, April 29, 2014 - 8:25am
tags:
Wockhardt, India, M&A
Bristol-Myers quarterly profit beats expectations as costs cut
Yahoo/Reuters
Tuesday, April 29, 2014 - 8:11am
tags:
Bristol-Myers Squibb, earnings
Bristol-Myers Squibb Acquires iPierian, Inc.
Yahoo
Tuesday, April 29, 2014 - 8:10am
tags:
iPierian, Bristol-Myers Squibb, M&A, IPN007
Merck 1st-quarter profit tops estimate, but revenue misses
CNBC
Tuesday, April 29, 2014 - 8:07am
tags:
earnings, Merck
Reforming The FDA Can Save $900 Million Annually And Generate $4 Trillion In Annual Social Value
Forbes
Tuesday, April 29, 2014 - 7:45am
tags:
FDA
Amicus Therapeutics fat disorder drug effective in trial
Yahoo/Reuters
Tuesday, April 29, 2014 - 7:37am
tags:
Amicus Therapeutics, Migalastat HCl, Fabry's disease
Irreconcilable differences? Allergan investors wary of suitor Valeant's cost-slashing style
Fierce Pharma
Monday, April 28, 2014 - 5:56pm
tags:
Allergan, Valeant Pharmaceuticals
Will Boston Scientific (BSX) Beat Earnings This Quarter?
Yahoo/Zacks.com
Monday, April 28, 2014 - 5:54pm
tags:
earnings, Boston Scientific, devices
Will Bristol-Myers (BMY) Beat Q1 Earnings?
Yahoo/Zacks.com
Monday, April 28, 2014 - 5:52pm
tags:
earnings, Bristol-Myers Squibb

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.